Ординатура / Офтальмология / Английские материалы / Applied Pathology for Ophthalmic Microsurgeons_Naumann, Holbach, Kruse_2008
.pdf
|
|
5.5.7 Complications After Cataract Surgery and Wound Healing 251 |
||
affected. The true seal needed for the formation of So- |
have been used to try to reduce the proliferative capaci- |
|||
emmerring’s ring occurs only if the cut edge of the an- |
ty of lens epithelial cells and hence PCO. |
|||
terior capsule comes into contact with the posterior |
|
An anterior capsulectomy can be considered an epi- |
||
capsule, because either the IOL optic is smaller than the |
thelial wound creating a stimulus to close the defect by |
|||
opening or the capsule has retracted beyond the edge of |
lens epithelial proliferation, migration and pseudo- |
|||
the optic (Fig. 5.5.36). |
metaplasia. Originally the consensus was, that to re- |
|||
The ring has two important functions. First, the |
move more of the anterior capsule would remove more |
|||
haptics of an implanted IOL, which extend to the equa- |
lens epithelial cells and therefore reduce the risk of |
|||
tor of the capsular bag, are held in place, which pre- |
PCO. It is now thought that the wider the opening, the |
|||
vents decentration. Second, the early fibrosis which is |
greater the number of epithelial cells released from |
|||
known to seal the capsular surfaces may help to contain |
contact inhibition, and therefore the greater the num- |
|||
the Elschnig’s pearls by enhancing the seal between |
ber of cells capable of proliferation and migration onto |
|||
these two surfaces. Some surgeons, therefore, believe |
the posterior capsule. Cases of PCO are less prevalent in |
|||
that to keep the cut edge of the anterior capsular flap in |
patients who undergo a circular capsulorrhexis, be- |
|||
front of the optic will ensure that the residual cells are |
cause this technique enhances the efficiency of hydro- |
|||
kept further away from the center of the posterior cap- |
dissection, subsequent cortical clean-up and shortens |
|||
sule and thus reduce the incidence of PCO. |
the lens of the “capsule wound.” The implantation of a |
|||
|
posterior chamber IOL into the capsular bag after cata- |
|||
5.5.7.2.4 |
ract extraction is known to reduce the likelihood that a |
|||
patient will develop PCO, because the IOL acts as a me- |
||||
Other Causes of PCO |
||||
chanical barrier and may delay the migration of cells |
||||
|
||||
Cell types other than lens epithelial cells may be in- |
around and into the center of the posterior capsule. |
|||
volved in PCO formation. Cataract surgery is associat- |
|
Patients who develop PCO with significantly im- |
||
ed with a breakdown of the blood-aqueous barrier, al- |
paired vision need a posterior capsulotomy achieved |
|||
lowing inflammatory cells, erythrocytes, and many |
by Nd:YAG laser. Complications of this procedure in- |
|||
other components to be released from the blood into |
clude transient and long-term IOP rise, dislocation of |
|||
the aqueous humor. This elicits an inflammatory re- |
the lens implant, rupture of the anterior vitreous face |
|||
sponse of variable severity, which may be increased by |
and anterior displacement of the vitreous, retinal de- |
|||
the implantation of an IOL. This foreign body reaction |
tachment, and cystoid macular edema. The incidence |
|||
elicits an immune response that involves many differ- |
of retinal detachment after Nd:YAG laser capsulotomy |
|||
ent cell types including polymorphonuclear leuko- |
is approximately 1 %. |
|||
cytes, giant cells, and fibroblasts. As a result, collagen is |
|
|
|
|
deposited onto the IOL and the capsule, which causes |
|
|
|
|
5.5.7.3 |
|
|||
opacities, and fine wrinkles may form in the posterior |
|
|||
Pseudophakia and Complications |
||||
capsule. In most cases, however, this inflammatory re- |
||||
|
|
|
||
sponse is clinically insignificant. |
Correction of aphakia after cataract extraction has long |
|||
|
been a dream of mankind which was only recently ful- |
|||
5.5.7.2.5 |
filled after a long period of trial and error between the |
|||
secular breakthrough of implantation of the first artifi- |
||||
Prevention and Treatment of PCO |
||||
cial lens (by Ridley in 1949) and today’s standardized |
||||
|
||||
As yet there is no reliable treatment to prevent PCO. Ex- |
extracapsular cataract extraction usually with phakoe- |
|||
perimental approaches being assessed include refine- |
mulsification avoiding a large corneoscleral wound or |
|||
ment of surgical technique, changes to the IOL design, |
after nuclear expression with IOL implantation. |
|||
modifications of the IOL surface, and the development |
|
Aside from multiple steps in technical details re- |
||
of pharmacological strategies either to kill all residual |
garding lens design, medications, instrumentation, mi- |
|||
epithelial cells or to prevent their proliferation and mi- |
croscopes, temperature of the infusion fluid (Mache- |
|||
gration. Ideally, the best way to prevent PCO would be |
mer, see chapter 4), two pioneering breakthroughs en- |
|||
to remove all the lens epithelial cells and the cortical |
abled the current state of the art: |
|||
remnants at the time of surgery. Many different ap- |
|
Kelman (1967) modified the aspiration/irrigation |
||
proaches have been used with variable success. Infu- |
system of the Fuchs’ syringe by developing the tech- |
|||
sion of sterile saline or water under the capsule rup- |
nique of phacoemulsification in the 1960s. Fankhauser |
|||
tures many, if not all, of residual epithelial cells (Maloof |
et al. (1981) pioneered the use of the YAG laser for clear- |
|||
et al. 2005). Anterior capsule cleaning with an ultraso- |
ing the opacities created by axial secondary cataract |
|||
nographic irrigating scratcher removes all fibers and |
without opening the eye. |
|||
reduces the number of residual epithelial cells. Phar- |
|
In the first 20 years after Ridley, the problem of fixa- |
||
macologic agents, antimetabolites, and other agents |
tion of the IOL implant had to be explored: Mobile lens |
|||

BP